G
1.61
0.79 (95.67%)
| Previous Close | 0.823 |
| Open | 0.840 |
| Volume | 33,741,955 |
| Avg. Volume (3M) | 968,530 |
| Market Cap | 1,906,431 |
| Price / Book | 0.650 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -3,442.80 |
| Total Debt/Equity (MRQ) | 3.61% |
| Current Ratio (MRQ) | 4.85 |
| Operating Cash Flow (TTM) | -12.49 M |
| Levered Free Cash Flow (TTM) | -8.06 M |
| Return on Assets (TTM) | -161.01% |
| Return on Equity (TTM) | -694.34% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | GlucoTrack, Inc. | - | - |
AIStockmoo Score
0.0
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | NA |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Relative Valuation | NA |
| Financial Health | NA |
| Macro Environment | 0.0 |
| AI Insight | NA |
| Weighted Average | 0.00 |
Select this tab to load the latest available analysis.
|
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 8.79% |
| % Held by Institutions | 1.27% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |